MTCR Gains 18.7%

Wed, Dec 15, 2021 at 05:30 PM

MTCR (MTCR:NASDAQ) soared at $1.46, representing a gain of 18.7%. From Tue, Nov 30, 2021, the stock recorded 40.00% Up Days and 54.55% Green Days

The stock spiked on Fri, Nov 19, 2021 at $1.47 with a volume of 3M+.

About MTCR (MTCR:NASDAQ)

Metacrine Inc is a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal diseases.

Top 10 Gainers:

THRX (THRX:NASDAQ), 34.12%
Cabot Microelectronics Corporation (CCMP:NASDAQ), 33.93%
BFRI (BFRI:NASDAQ), 26.36%
American Virtual Cloud Technologies, Inc. (AVCT:NASDAQ), 25.41%
Regional Health Properties, Inc. (RHE:NYSEMKT), 23.84%
GMTX (GMTX:NASDAQ), 23.05%
CNEY (CNEY:NASDAQ), 22.36%
Mesoblast Limited (MESO:NASDAQ), 19.18%
BSN (BSN:NYSE), 19.06%
MTCR (MTCR:NASDAQ), 18.7%